Search
Now showing items 1-6 of 6
Modeling of In vitro Release Kinetics of Ultrasound-triggered Targeted Liposomes
(2022-04)
Ultrasound-triggered, targeted liposomes are a promising drug delivery system as they potentially improve the clinical outcomes of chemotherapy while reducing associated side effects. However, the common drug release models ...
Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review
(Bentham Science Publisher, 2021)
Nanoparticles have proven promising as cancer theranostic tools. Nanoparticles are selective in nature, have reduced toxicity, and controllable drug release patterns making them ideal carriers for anticancer drugs. Numerous ...
A Novel Cancer Treatment Platform Utilizing HER2-Immunoliposomes and Ultrasound
(2020-05)
Cancer is defined as the uncontrolled growth of cells in the body. It is one of the leading causes of death worldwide. One of the most common approaches to destroy cancer cells is via chemotherapy treatment, in which ...
Encapsulation and release of calcein from herceptin-conjugated eLiposomes
(Elsevier, 2024-03)
Achieving an optimal therapeutic level is crucial in effectively eradicating cancer cells during treatment. However, conventional chemotherapy-associated systemic administration of anticancer agents leads to many side ...
Hybrid liposome/metal–organic framework as a promising dual-responsive nanocarriers for anticancer drug delivery
(Elsevier, 2022)
In this work, liposome-coated iron (III) benzene-1,3,5-tricarboxylate (Fe-BTC) metal–organic framework is examined as a promising pH/Ultrasound dual-responsive nanocarriers for doxorubicin (DOX) delivery. The successful ...